The Queen's University of Belfast Patent applications |
Patent application number | Title | Published |
20160137767 | PARTICLES FOR ELECTROPHORETIC DISPLAYS - This invention relates to polymer particles, a process for their preparation, electrophoretic fluids comprising such particles, and electrophoretic display devices comprising such fluids. | 05-19-2016 |
20160052838 | OLIGOMERISATION PROCESS - This invention relates to base oils for lubricating compositions. In particular, the present invention provides a process for the selective oligomerisation of C5 to C20 alpha-olefins to produce polyalphaolefin oligomers with a molecular weight distribution that is suitable for use in lubricant base oils. | 02-25-2016 |
20150185229 | BIOMARKER OF RENAL DYSFUNCTION - The present invention relates to a method for determining predisposition of a subject to developing renal dysfunction induced by physical trauma, hypotension, sepsis and/or septic shock syndrome, wherein the method comprises the steps of:—a. determining the level of an anti-inflammatory cytokine present in a sample taken from the subject prior to physical trauma, prior to a hypotensive event, prior to sepsis, and/or prior to septic shock syndrome; b. determining if the subject is predisposed to developing renal dysfunction following physical trauma, hypotension, sepsis and/or septic shock syndrome on the basis of the level of an anti-inflammatory cytokine determined in step a). | 07-02-2015 |
20150126480 | BIOMARKER OF RENAL DYSFUNCTION - The present invention relates to a method for a method for predicting the development of renal dysfunction in a subject following physical trauma, hypotension, sepsis and/or septic shock syndrome, wherein the method comprises the steps of: —a. determining the level of an anti-inflammatory cytokine present in a sample taken from the subject after physical trauma, after a hypotensive event, after sepsis, and/or after septic shock syndrome; b. predicting the development in the subject of renal dysfunction on the basis of the level of an anti-inflammatory cytokine determined in step a). | 05-07-2015 |
20150047402 | CONTROLLED RELEASE FERTILISER - The present invention provides a fertiliser comprising nutrients adsorbed onto a core material comprising a carbonate mineral. Also provided are methods of producing a solid fertiliser, the method comprising adsorbing nutrients onto a core material comprising a carbonate mineral. The invention also provides a method for treating waste material by anaerobic digestion to produce a nutrient rich liquor and adsorbing nutrients from this liquor onto a core material comprising a carbonate mineral. Also provided are the uses of a carbonate mineral for adsorbing phosphorus from anaerobic digestion liquor and for the control release of phosphorus from a fertiliser. | 02-19-2015 |
20140235430 | METHOD AND APPARATUS FOR TESTING A CATALYST MATERIAL - A method of ageing a catalyst material includes at least the steps of: (a) heating a gaseous stream; (b) adding a least one pure hydrocarbon gas and an oxygen-containing gas to the heated gaseous stream to provide a combined stream; and (c) passing the combined stream through the catalyst material. The use of at least one pure hydrocarbon gas and an oxygen-containing gas allows maximum re-circulation of the exit stream from the catalyst material for reuse, while maintaining the correct C, H and O proportions being provided in the combined stream to replicate realistic use of the catalyst material. | 08-21-2014 |
20140127689 | CXCR1 AS A PREDICTOR OF RESPONSE TO TREATMENT WITH EPIDERMAL GROWTH FACTOR RECEPTOR THERAPEUTIC - There is provided a molecular marker CXCR1 for predicting response and survival in subjects afflicted with cancer who would benefit from treatment with and Epidermal Growth Factor Receptor (EGFR) targeted therapeutic. | 05-08-2014 |
20140091008 | PROCESS FOR REMOVING NAPHTHENIC ACIDS FROM CRUDE OIL AND CRUDE OIL DISTILLATES - The present invention relates to a process for the removal of naphthenic acids from crude oils and crude oil distillates by use of supported basic ionic liquids. | 04-03-2014 |
20140001100 | PROCESS FOR REMOVING METALS FROM HYDROCARBONS | 01-02-2014 |
20130203602 | SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS - The present invention relates to biologically active compounds, particularly liquid compounds, which are immobilized on a solid carrier material, particularly on mesoporous silica. The compounds are non-covalently supported on the solid carrier material thereby forming stable, easily handled solids which have the further advantage that the adsorbed biologically active compounds have improved thermal stability compared with the non-adsorbed compounds, and that they are released rapidly and completely from the carrier material when placed in an aqueous environment. | 08-08-2013 |
20130034891 | CONVERSION METHOD - A process is described for the preparation of water-soluble cellulose hydrolysis product. The process comprise admixing cellulose with an ionic liquid capable of solvating or dissolving at least some of the cellulose, said ionic liquid being a compound comprises solely of cations and anions and which exists in a liquid state at a temperature at or below 150° C., and in which the anions are selected from halide and cyanate; and treating the resulting solvate or solution with an acid in the presence of water, said acid having a pKa in water of less than 2 at 25° C. | 02-07-2013 |
20120295851 | PEPTIDES, COMPOSITIONS AND USES THEREOF - Described is an N-terminal hexapeptide fragment of maximakinin, QUB 698.8, which exhibits potent tissue selective actions on smooth muscle. It demonstrates a high degree of selectivity for arterial smooth muscle over small intestinal smooth muscle, causing potent relaxation of arterial smooth muscle, while causing less potent contraction of ileal smooth muscle. It may be used treatment of diseases of the cardiovascular system and in promotion of angiogenesis. | 11-22-2012 |
20120029247 | CONVERSION METHOD - A process is described for the preparation of water-soluble cellulose hydrolysis products, which comprises admixing cellulose with an ionic liquid capable of solvating or dissolving at least some of the cellulose, said ionic liquid being a compound comprised solely of cations and anions and which exists in a liquid state at a temperature at or below 15O° C., the cations in said ionic liquid having the general formula (I), in which Z represents a nitrogen or phosphorus atom, R | 02-02-2012 |
20110312048 | CONVERSION METHOD - A process is described for the preparation of water-soluble cellulose hydrolysis products The process comprises admixing cellulose with an ionic liquid capable of solvating or dissolving at least some of the cellulose, said ionic liquid being a compound comprised solely of cations and anions and which exists in a liquid state at a temperature at or below 15O° C., and in which the anions are selected from sulfate, hydrogen sulfate and nitrate; and treating the resulting solvate or solution with an acid in the presence of water, said acid having a pKa in water of less than 2 at 25° C. | 12-22-2011 |
20110251050 | METHOD AND APPARATUS FOR TESTING A CATALYST MATERIAL - A method of ageing a catalyst material includes at least the steps of: (a) heating a gaseous stream; (b) adding a least one pure hydrocarbon gas and an oxygen-containing gas to the heated gaseous stream to provide a combined stream; and (c) passing the combined stream through the catalyst material. The use of at least one pure hydrocarbon gas and an oxygen-containing gas allows maximum re-circulation of the exit stream from the catalyst material for reuse, while maintaining the correct C, H and O proportions being provided in the combined stream to replicate realistic use of the catalyst material. | 10-13-2011 |
20110202324 | SYSTEM AND METHODS FOR ACCELERATING SIMULATION OF RADIATION TREATMENT - A method for estimating a radiation dose and distribution for a target volume is provided. The method includes receiving a simulated dose array ( | 08-18-2011 |
20100249035 | PEPTIDES, COMPOSITIONS AND USES THEREOF - Described is an N-terminal hexapeptide fragment of maximakinin, QUB 698.8, which exhibits potent tissue selective actions on smooth muscle. It demonstrates a high degree of selectivity for arterial smooth muscle over small intestinal smooth muscle, causing potent relaxation of arterial smooth muscle, while causing less potent contraction of ileal smooth muscle. It may be used treatment of diseases of the cardiovascular system and in promotion of angiogenesis. | 09-30-2010 |
20100240579 | DETECTION OF CELL SURFACE BINDING MOLECULES USING A PHAGE DISPLAY BLOCKING ASSAY - The present invention relates to the use of a phage blocking assay to determine unknown binding molecule present on or in the surface of a cell, a non-infectious moiety, a bacteria, a virus, or another pathogen. In particular embodiments, the invention relates to the identification of unknown receptors on a cell or virus involved in infection. Further, it relates to the use of said binding molecules, for example virus binding molecules or cellular receptors and binding members with binding specificity to said binding molecules, for example antibodies, in methods of therapy. | 09-23-2010 |
20100143741 | METHOD OF COATING A METALLIC ARTICLE WITH A SURFACE OF TAILORED WETTABILITY - A method of coating a metallic article having an at least part-metallic surface comprising a first metal, with a surface having a pre-determined wettability, the method at least comprising the steps of: (a) coating at least a part of the metallic article with a layer of a second metal to provide a metal-metal bonded surface, said surface being rough either prior to or because of step (a); and (b) contacting the metal-metal bonded surface of step (a) with a material to provide the surface having the pre-determined wettability. The first metal may be one or more of the group comprising: iron, zinc, copper, tin, nickel and aluminium, and alloys thereof including steel, brass, bronze and nitinol for example. Preferably, the second metal is coated onto the first metal using electroless Galvanic deposition. The nature of the coated metallic article is non-limiting, as the ability of the present invention is to provide a tailored surface with a pre-determined wettability thereon, including superhydrophobic and superhydrophilic wettability. This allows the invention to be capable of application to a wide range of metal types used in different fields. | 06-10-2010 |
20100015025 | PROCESS FOR PREPARING HYDROXYLAPATITE - A process for preparing hydroxylapatite from a calcium carbonate-containing algae comprising the steps of: (a) converting at least some of the calcium carbonate in the algae to calcium oxide without changing the porosity of the algae; and (b) reacting the so-formed material of step (a) with phosphate ions in water. | 01-21-2010 |
20100004169 | CCN3 peptide - The present application relates to nucleic acid and peptide sequences of CCN3 and derivatives and fragments thereof useful in the treatment of disease, in particular tumours and/or for use as a clinical marker. | 01-07-2010 |
20090325219 | DEVICE, SYSTEM AND ASSAY FOR MEASURING CELL MOTILITY - The present application relates to a device and system for measuring cell motility comprising a supporting substrate which includes at least one cell receiving zone and an agent receiving matrix provided on a matrix receiving zone, wherein interposed between the cell receiving zone and the agent receiving matrix is a bridging portion. In addition, methods of using said device and system and a kit relating to the device is provided. | 12-31-2009 |
20090312394 | Protection against and treatment of age related macular degeneration - Methods and reagents in relation to the diagnosis, protection and treatment of Age Related Macular Degeneration (AMD). In particular, the methods and reagents in relation to RNA; determined to provide a strong protection to a subject against development of AMD. | 12-17-2009 |
20090309090 | Nanostructures and a Method for the Manufacture of the Same - A nanostructure comprising a first structure comprising conductive material, which is attached to a second structure comprising one or more portions of conductive material separated by insulator material, which is attached to a third structure comprising a material in which a change can be effected. The third structure may comprise a dielectric or ferroelectric material, and the change effected in the material may be polarization of the material. The nanostructure may comprise one or more nanocapacitors, each of which comprises a part of the third structure in which a change comprising polarization may be effected. The nanocapacitors may be used to store data. | 12-17-2009 |
20090292357 | MATERIAL AND USES THEREOF - A material comprising at least one polymer and at least one sensitizer wherein the sensitizer is localised at a surface of the material wherein the sensitizer is an agent or compound able to provide improved anti-bacterial and/or anti-viral activity following exposure of the sensitizer to a particular wavelength or range of wavelengths of electromagnetic radiation. | 11-26-2009 |
20090270248 | Basic ionic liquids - Use of ionic liquids as solvents in base-catalysed chemical reactions wherein the ionic liquid is composed of at least one species of cation and at least one species of anion, characterised in that a cation of the ionic liquid comprises a positively charge moiety and a basic moiety, and further wherein such ionic liquids may be used as promoters or catalysts for the chemical reactions. | 10-29-2009 |
20090216015 | Base Stable Ionic Liquids - The present invention relates to novel base stable ionic liquids and uses thereof as solvents in chemical reactions, especially base catalysed chemical reactions and reactions comprising the use of strong basis. | 08-27-2009 |
20090208446 | DUB3 as a Cancer Therapy Target - Described is a method of modulating the activation of a Rho, Arf, Rab, Ran or Rap family protein, said method comprising administering to said sample a USP-17 modulator, for example an inhibitor of expression or activity of DUB-3. The invention enables the use of USP-17 modulators in the treatment of metastatic cancer and other conditions. | 08-20-2009 |
20090143595 | Use of grinding in chemical synthesis - A process for the preparation of a multi-dimensional microporous metal-organic compound comprising the steps of providing a first reactant which includes at least one metal in ionic form, providing a second reactant which includes a bridging organic ligand, grinding the first and second reactants together, wholly or substantially in the absence of solvent. | 06-04-2009 |
20090069494 | Polymer material - A process is described for providing a polymer material by blending as a first component one or more hydrophilic polymers, and as a second component one or more neutralising chemicals, in the complete or substantial absence of water. In the absence of water, the components will not be aqueous solutions. Thus the components can be used in blending processes, and the present invention is able to form many other shapes and forms of material other than laminates on substrates. | 03-12-2009 |
20090068198 | Antibody and Uses Thereof - Described are specific binding members e.g. antibodies which may be used in the treatment of diseases associated with cathepsin S activity. The specific binding members binds cathepsin S and inhibits its proteolytic activity. The binding members may be used in the treatment of diseases such as cancer, inflammatory diseases, neurodegenerative disorders, autoimmune disorders, and other diseases associated with excessive, deregulated or inappropriate angiogenesis. | 03-12-2009 |
20080317662 | Molten Salts, Method of Their Production and Process for Generating Hydrogen Peroxide - A molten salt and process for preparing a molten salt or hydrogen peroxide uses ionic hydroquinones or hydroquinone derivatives as O | 12-25-2008 |
20080306319 | Oligomerisation - The application discloses novel processes for the oligomerisation of unsaturated hydrocarbons, and more specifically the use of selected ionic liquids in the oligomerisation of unsaturated hydrocarbons, which allows for selection of the oligomers formed. | 12-11-2008 |
20080268435 | Brca1 Markers - A method of predicting the presence of a non-functional BRCA1 gene in a biological sample, comprises the step of assaying the sample for expression of at least one specific member of the S100 family of genes. The invention also describes a kit for predicting the presence of non-functional BRCA1, comprising means for assaying a sample for expression of at least one specific member of the S100 gene family. A method of detecting a genetic predisposition to cancer is also described, comprising the step of assaying a biological sample for expression of a specific member of the S100 family of genes. Also described is a method of determining a suitable chemotherapeutic agent for an individual. | 10-30-2008 |
20080204355 | Frequency Selective Surfaces - A freestanding frequency selective surface (FSS) is provided which comprises at least one shorted resonance aperture element ( | 08-28-2008 |